SEC Form 4/A · accession 0001612627-26-000007
Inhibrx Biosciences, Inc. · INBX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
This is an amendment (Form 4/A). It replaces an earlier filing for the same period.
Reporting owner
Kristiina Vuori M.D.
Director
Period of report
Jun 3, 2026
Accepted (ET)
Sep 18, 2026 · 4:25 pm EDT
Rule 10b5-1 plan
box not checked
Issuer CIK
0002007919
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy)F1 | $95.22 | Jun 3, 2026 | A | 10,000 | A | Jun 3, 2027 | Jun 3, 2036 | Common Stock | 10,000 | 10,000 | D |
Explanation of responses
- F1This stock option will be fully exercisable on June 3, 2027, subject to the reporting person's continued service through such date.
Remarks
This Amended Form 4 restates the original Form 4 filed on June 4, 2026 in its entirety to correct the number of options granted to the Reporting Person due to an administrative error.